tocilizumab - dofaq.co
Tocilizumab, un medicament folosit pentru artrită, reduce riscul de deces la pacienții cu forme grave de...
Digi24 - 12 Feb 2021
Tocilizumab, un medicament folosit pentru artrită, reduce riscul de deces la pacienții cu forme grave de... ...
Medicamentul Tocilizumab a fost folosit cu succes în Franța pe pacienții care suferă forme severe…
Economica.net - 27 Apr 2020
Medicamentul Tocilizumab a fost folosit cu succes în Franța pe pacienții care suferă forme severe… ...
WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19
World Health Organization (WHO) - 11 Feb 2022
WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19 ...
FDA Approves Second Tocilizumab Biosimilar
Medscape - 07 Mar 2024
FDA Approves Second Tocilizumab Biosimilar ...
Tocilizumab, second drug ever recommended by WHO for COVID-19, will remain unaffordable and inaccessible for ...
MSF Access Campaign - 06 Jul 2021
Tocilizumab, second drug ever recommended by WHO for COVID-19, will remain unaffordable and inaccessible for ... ...
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience ...
Nature - 20 Dec 2023
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience ... ...
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia | New England Journal of Medicine
The New England Journal of Medicine - 17 Dec 2020
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia | New England Journal of Medicine ...
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis - Infectious Diseases of Poverty
BioMed Central - 18 May 2021
Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis - Infectious Diseases of Poverty ...
Tocilizumab reduces deaths in patients hospitalised with COVID-19
RECOVERY Trial - 11 Feb 2021
Tocilizumab reduces deaths in patients hospitalised with COVID-19 ...
Actemra/RoActemra (tocilizumab)
Roche - 22 Feb 2022
Actemra/RoActemra (tocilizumab) ...
FDA approves Tofidence, a biosimilar referencing Actemra
Pharmaceutical Technology - 26 Oct 2023
FDA approves Tofidence, a biosimilar referencing Actemra ...
Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients
ScienceDirect.com - 15 Mar 2020
Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients ...
The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19 ...
Nature - 06 Feb 2024
The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19 ... ...
MSF response to Roche's statement on access to tocilizumab
MSF Access Campaign - 09 Jul 2021
MSF response to Roche's statement on access to tocilizumab ...
European Commission Approves First Tocilizumab Biosimilar
Medscape - 20 Sep 2023
European Commission Approves First Tocilizumab Biosimilar ...
Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid ...
Nature - 20 Oct 2022
Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid ... ...
Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA
Medscape - 12 Apr 2024
Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA ...
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis | Scientific Reports
Nature - 03 Jun 2023
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis | Scientific Reports ...
Tocilizumab degradation via photo-catalytic ozonation process from aqueous | Scientific Reports
Nature - 16 Dec 2023
Tocilizumab degradation via photo-catalytic ozonation process from aqueous | Scientific Reports ...